Skip to content

Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children

Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00456469
Acronym
ALTAC
Enrollment
500
Registered
2007-04-05
Start date
2007-05-31
Completion date
2009-10-31
Last updated
2007-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

TB, latent, infection, Ethiopia

Brief summary

Study based in Southern Ethiopia Purpose - to explore if children in contact with adults with TB have positive acute reactants such as IFN-y and other cytokine responses; if these responses discriminate between high and low risk of disease progression and whether these could be incorporated into improved diagnostic approaches.

Detailed description

The study follows children in contact with TB. Those with positive TST will be offered chemoprophylaxis and all children will be followed for 2 years to describe IFN-y responses over time, identify symptoms of active TB and if these symptoms are associated with IFN-y and other cytokine responses. Children with suspicion of TB attending health centres will also be investigated using routine diagnostic tests and IFN-y and other cytokines responses to evaluate if the latter could be used in improved diagnostic approaches.

Interventions

None listed

Sponsors

Thrasher Research Fund
CollaboratorOTHER
Liverpool School of Tropical Medicine
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

\- Children - 1 to 14 years old in contact with adults with smear positive TB Or: \- Children with suspicion of TB admitted to the hospital for investigations

Exclusion criteria

\- Residency \> 10 Km from recruitment center Or: \- Patient severely to undergo diagnostic procedures.

Countries

Ethiopia

Contacts

Primary ContactLuis Cuevas, MD MTropMed
lcuevas@liv.ac.uk0151 705 3219

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026